NBSE Gross Margin

The Gross Margin of NeuBase Therapeutics Inc (NBSE) is -900.00%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

NBSE Gross Margin - Historical Value

Date	Value
2022-12-31	-900.00%

NBSE Gross Margin - Peers Comparison

Ticker	Name	Value
AEZS.TO	Aeterna Zentaris Inc	95.06%
APTX	Aptinyx Inc	7775.20%
MRKR	Marker Therapeutics Inc	7775.20%
NYMX	Nymox Pharmaceutical Corp	-
TARA	Protara Therapeutics Inc	7775.20%
ABBV	Abbvie Inc	69.99%
ABEO	Abeona Therapeutics Inc	100.00%
CELC	Celcuity Inc	7775.20%
GLTO	Galecto Inc	7775.20%
GNPX	Genprex Inc	7775.20%
LTRN	Lantern Pharma Inc	7775.20%
950160.KQ	Kolon TissueGene Inc	11.72%
950200.KQ	Psomagen Inc	23.13%
ATOS	Atossa Therapeutics Inc	100.00%
IMV.TO	IMV Inc	7775.20%
XFOR	X4 Pharmaceuticals Inc	68.83%
AMGN	Amgen Inc	61.53%
FENC	Fennec Pharmaceuticals Inc	93.30%
GRCL	Gracell Biotechnologies Inc	7775.20%
OBSV	Obseva SA	7775.20%
ONCS	OncoSec Medical Inc	7775.20%
PSTI	Pluristem Therapeutics Inc	100.00%
REGN	Regeneron Pharmaceuticals Inc	87.01%
DMAC	DiaMedica Therapeutics Inc	7775.20%
ENLV	Enlivex Therapeutics Ltd	7775.20%
MDNA.TO	Medicenna Therapeutics Corp	7775.20%
950220.KQ	Neoimmunetech Inc	7775.20%
GILD	Gilead Sciences Inc	78.26%
MTNB	Matinas BioPharma Holdings Inc	-422.88%
VRTX	Vertex Pharmaceuticals Inc	86.11%
AXLA	Axcella Health Inc	7775.20%
PHGE	Biomx Inc	7775.20%
RVX.TO	Resverlogix Corp	7775.20%
ENOB	Enochian Biosciences Inc	100.00%
MRNA	Moderna Inc	70.06%
MTCR	Metacrine Inc	7775.20%